Suppr超能文献

多态转运体与铂类药物药效动力学。

Polymorphic transporters and platinum pharmacodynamics.

机构信息

Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

出版信息

Drug Metab Pharmacokinet. 2013;28(1):19-27. doi: 10.2133/dmpk.dmpk-12-rv-073. Epub 2012 Sep 18.

Abstract

Several solute carriers and ATP-binding cassette transporters have been implicated in the influx or efflux of platinum-based chemotherapeutic agents such as cisplatin, carboplatin, and oxaliplatin. Given that many of these proteins are highly polymorphic, the genetic status of these proteins could be an important contributor to the extensive interindividual pharmacokinetic variability associated with the clinical use of these agents. In this review article, we provide an updated overview of the various transporters that have shown promise in animal models or patient populations in facilitating the movement of platinum-based agents across cell membranes, and how their function is associated with drug disposition or pharmacodynamic effects.

摘要

几种溶质载体和 ATP 结合盒转运蛋白已被牵涉到铂类化疗药物(如顺铂、卡铂和奥沙利铂)的流入或流出中。鉴于这些蛋白质中的许多都是高度多态的,这些蛋白质的遗传状态可能是与这些药物临床应用相关的广泛个体间药代动力学变异性的重要因素。在这篇综述文章中,我们提供了一个更新的概述,介绍了在动物模型或患者群体中表现出有希望促进铂类药物穿过细胞膜运动的各种转运蛋白,以及它们的功能如何与药物处置或药效学效应相关联。

相似文献

1
Polymorphic transporters and platinum pharmacodynamics.
Drug Metab Pharmacokinet. 2013;28(1):19-27. doi: 10.2133/dmpk.dmpk-12-rv-073. Epub 2012 Sep 18.
2
Membrane transporters as determinants of the pharmacology of platinum anticancer drugs.
Curr Cancer Drug Targets. 2012 Oct;12(8):962-86. doi: 10.2174/156800912803251199.
3
Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2).
Br J Pharmacol. 2010 Feb;159(4):898-908. doi: 10.1111/j.1476-5381.2009.00569.x. Epub 2010 Jan 8.
4
Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.
Cancer Chemother Pharmacol. 2008 Sep;62(4):577-84. doi: 10.1007/s00280-007-0640-3. Epub 2007 Nov 21.
5
Role of copper transporters in the uptake and efflux of platinum containing drugs.
Cancer Lett. 2006 Mar 8;234(1):34-9. doi: 10.1016/j.canlet.2005.07.046. Epub 2005 Nov 16.
6
Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs.
Mol Pharmacol. 2010 Jun;77(6):887-94. doi: 10.1124/mol.109.063172. Epub 2010 Feb 16.
7
Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs.
Crit Rev Oncol Hematol. 2005 Jan;53(1):13-23. doi: 10.1016/j.critrevonc.2004.09.007.
8
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy.
Annu Rev Pharmacol Toxicol. 2008;48:495-535. doi: 10.1146/annurev.pharmtox.48.080907.180426.
10
The roles of copper transporters in cisplatin resistance.
Cancer Metastasis Rev. 2007 Mar;26(1):71-83. doi: 10.1007/s10555-007-9045-3.

引用本文的文献

1
Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies.
Front Pharmacol. 2023 Aug 1;14:1231401. doi: 10.3389/fphar.2023.1231401. eCollection 2023.
5
An Update in Our Understanding of the Relationships Between Gene Polymorphisms and Chemotherapy-Induced Nausea and Vomiting.
Int J Gen Med. 2021 Sep 18;14:5879-5892. doi: 10.2147/IJGM.S329257. eCollection 2021.
6
Emerging roles of the solute carrier family in pancreatic cancer.
Clin Transl Med. 2021 Mar;11(3):e356. doi: 10.1002/ctm2.356.
8
Platinum accumulation in oxaliplatin-induced peripheral neuropathy.
J Peripher Nerv Syst. 2021 Mar;26(1):35-42. doi: 10.1111/jns.12432. Epub 2021 Jan 27.
9
Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions.
Rev Physiol Biochem Pharmacol. 2022;183:177-215. doi: 10.1007/112_2020_30.

本文引用的文献

2
Associations between ABCC2 polymorphisms and cisplatin disposition and efficacy.
Clin Pharmacol Ther. 2012 Jun;91(6):1022-6. doi: 10.1038/clpt.2011.330.
3
Ameliorative effects of SLC22A2 gene polymorphism 808 G/T and cimetidine on cisplatin-induced nephrotoxicity in Chinese cancer patients.
Food Chem Toxicol. 2012 Jul;50(7):2289-93. doi: 10.1016/j.fct.2012.03.077. Epub 2012 Apr 16.
5
Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury.
Food Chem Toxicol. 2012 May;50(5):1675-9. doi: 10.1016/j.fct.2012.02.082. Epub 2012 Mar 3.
9
Pharmacogenetic analyses of cisplatin-induced nephrotoxicity indicate a renoprotective effect of ERCC1 polymorphisms.
Pharmacogenomics. 2011 Oct;12(10):1417-27. doi: 10.2217/pgs.11.93. Epub 2011 Sep 8.
10
Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma.
BJU Int. 2011 Jul;108(2):168-79. doi: 10.1111/j.1464-410X.2011.10341.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验